Vivien Low

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “NADK-mediated de novo NADP(H) synthesis is a metabolic adaptation essential for breast cancer metastasis”.

NADK-mediated de novo NADP(H) synthesis is a metabolic adaptation essential for breast cancer metastasis

Redox Biology(2023)10.1016/j.redox.2023.102627

N/A

0.533DataRank · unranked

34 citations

Stanislav Drápela, Tanya Schild, Nathan P. Ward, Emma Adhikari, Vivien Low +7 more

Targeting the premetastatic niche: epigenetic therapies in the spotlight

Signal Transduction and Targeted Therapy(2020)10.1038/s41392-020-0165-3

N/A

0.385DataRank · unranked

12 citations

John Blenis, Ana P. Gomes, Vivien Low

Stromal KITL/SCF Maintains Pancreas Tissue Homeostasis and Restrains Tumor Progression

Cancer Discovery(2025)10.1158/2159-8290.cd-24-1079

N/A

0.208DataRank · unranked

3 citations

Chet Oon, Sohinee Bhattacharyya, Vivien Low, Canping Chen, Xiaofan Zhao +10 more

NADK upregulation is an essential metabolic adaptation that enables breast cancer metastatic colonization

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.25.485887

N/A

0.165DataRank · unranked

2 citations

Tanya Schild, Nathan P. Ward, Stanislav Drápela, Emma Adhikari, Vivien Low +5 more

Tumor-produced and aging-associated oncometabolite methylmalonic acid promotes cancer-associated fibroblast activation to drive metastatic progression

Nature Communications(2022)10.1038/s41467-022-33862-0

N/A

0DataRank · unranked

68 citations

Vivien Low, Valbona Luga, Janet Sun, Ethan M. Earlie, Bobak Parang +13 more

Altered propionate metabolism contributes to tumour progression and aggressiveness

Nature Metabolism(2022)10.1038/s42255-022-00553-5

N/A

0DataRank · unranked

113 citations

Didem Ilter, Vivien Low, Stanislav Drápela, Tanya Schild, Edouard Mullarky +13 more

NADK is activated by oncogenic signaling to sustain pancreatic ductal adenocarcinoma

Cell Reports(2021)10.1016/j.celrep.2021.109238

N/A

0DataRank · unranked

41 citations

Melanie R. McReynolds, Christie Shea, Vivien Low, Bethany E. Schaffer, John M. Asara +6 more

The emerging role of dysregulated propionate metabolism and methylmalonic acid in metabolic disease, aging, and cancer

Cell Metabolism(2025)10.1016/j.cmet.2025.01.005

N/A

0DataRank · unranked

28 citations

Vivien Low, Zhongchi Li, John Blenis, Moniquetta Shafer

Age-induced methylmalonic acid accumulation promotes tumor progression and aggressiveness

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.04.135087

N/A

0DataRank · unranked

1 citations

Didem Ilter, Vivien Low, Jennifer E. Endress, Juan Fernández-García, Adam Rosenzweig +16 more

Tumor-produced aging-associated oncometabolite, methylmalonic acid, promotes cancer-associated fibroblast activation to drive metastatic progression

Research Square(2022)10.21203/rs.3.rs-1643401/v1

N/A

0DataRank · unranked

0 citations

Vivien Low, Valbona Luga, Janet Sun, Ethan M. Earlie, Bobak Parang +13 more